Position in VRTX
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$5,563,871
-$926,587 QoQ
Shares Held
11,201
-22.9% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
#453
of 1,726 holders
Holding Since
Sep 2020
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FIRST HORIZON CORP holds $7,150,431 across 40 Biotechnology names. VRTX ranks #1 (77.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
11,201 | $5,563,871 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
615 | $383,476 | |
| 3 | TVTX |
Travere Therapeutics, Inc.
|
2,161 | $122,765 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
487 | $119,202 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
297 | $93,877 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
1,190 | $93,140 | |
| 7 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
1,088 | $88,682 | |
| 8 | INSM |
INSMED Inc
|
708 | $75,486 |
All Filings in VRTX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,563,871 | 11,201 | Shares | Defined | 2026-07-20 | |
| 2026-03-31 | $6,490,458 | 14,535 | Shares | Defined | 2026-04-30 | |
| 2025-12-31 | $5,510,590 | 12,155 | Shares | Defined | 2026-01-27 | |
| 2025-09-30 | $5,530,348 | 14,121 | Shares | Defined | 2025-10-27 | |
| 2021-06-30 | $20,566 | 102 | Shares | Defined | 2021-08-09 | |
| 2021-03-31 | $24,067 | 112 | Shares | Defined | 2021-05-11 | |
| 2020-12-31 | $21,034 | 89 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $31,293 | 115 | Shares | Defined | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||